Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

Abbott Laboratories 100 Abbott Park Road, Dept 943, Bldg AP6C-3 NORTH CHICAGO IL 60064-3502 USA

UEI: SLED_E26EFDE33F01C2D8

Abbott Laboratories 100 Abbott Park Road, Dept 943, Bldg AP6C-3 NORTH CHICAGO IL 60064-3502 USA is a federal contractor, registered under UEI SLED_E26EFDE33F01C2D8. It has been awarded $2,765,806 across 1 federal contract. Primary work spans In-Vitro Diagnostic Substance Manufacturing.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_E26EFDE33F01C2D8

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
$2.8M100%
Awards by NAICS
325413 - In-Vitro Diagnostic Substance Manufacturing$2.8M100%
Awards by Agency Over Time
Export
Awards by Place of Performance

Open opportunities in Abbott Laboratories 100 Abbott Park Road, Dept 943, Bldg AP6C-3 NORTH CHICAGO IL 60064-3502 USA's top NAICS codes and agencies

NAICS: 325413
New
Federal
6640--LAB - Immunochemistry (IHC) instrument
Solicitation # 36C24226Q0827
The Department of Veterans Affairs, through Network Contracting Office 2, intends to award a sole-source contract to Roche Diagnostics Corporation for proprietary reagent kits and consumables compatible with VA-owned Roche Benchmark Ultra Plus immunohistochemistry instruments. This action is justified under FAR 6.302-1 due to the technical exclusivity of the reagents, as no alternative suppliers can provide products that function with the existing VA equipment. The solicitation, identified by number 36C24226Q0827, was posted on July 22, 2026, with responses due by July 30, 2026, at 10:00 a.m. Eastern Time, submitted exclusively via email to the Contracting Officer, Aleta Jennette. The contract is for laboratory reagents essential to ongoing diagnostic operations, primarily at the James J. Peters VA Medical Center in Bronx, NY, though the final place of performance remains TBD. No competitive solicitation exists, and therefore no formal evaluation factors, pricing details, line items, or contract value have been established. The procurement is non-competitive, with no set-asides for small or socioeconomic businesses, and no socioeconomic certifications or UEI/CAGE codes for the vendor are provided. Packaging, marking, preservation, inspection, acceptance criteria, and invoicing methods are not specified, with assumed compliance to standard commercial practices for laboratory reagents. Contract administration oversight is limited to the Contracting Officer, with no designated COR, COTR, or PCO identified. The contracting office is located in Albany, NY, but administrative and performance functions are centered at the Bronx facility. No FAR clauses, special requirements, or representations from the offeror are included, as the document serves solely as a market research notice indicating intent to award without requiring formal proposals, quotes, or submissions other than expressions of interest. The acquisition is driven entirely by proprietary compatibility, with no alternatives available, rendering traditional contract elements such as pricing, delivery schedules, or payment terms unnecessary at this preliminary stage.
242-NETWORK Contract Office 02 (36C242)

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 325413
New
Federal
BRAND NAME OR EQUAL Flow Cytometry Reagents for the MPLS VA
Solicitation # 36C26326R0072
Solicitation 36C26326R0072 is a five-year Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract issued by the Department of Veterans Affairs, Network Contracting Office 23, for the procurement of brand-name or equal flow cytometry reagents. The contract is designed to support clinical immunophenotyping at the Minneapolis VA Health Care System, with a total period of performance running from October 1, 2026, through September 30, 2031. This duration consists of a base period followed by four one-year ordering periods. The procurement is justified as a sole-source award under FAR 6.103-1 and 12.102(a) because the required Becton Dickinson (BD) reagents are proprietary and the only products compatible with the facility's existing BD FACSCanto, FACSLyric, and FACS Lyse Wash Assistant instrumentation. The scope of work involves the supply of a specific catalog of BD reagents, including various CD antigens and fluorochromes, with estimated annual quantities ranging from 2 to 60 units per item. All deliveries and performance will occur at the Minneapolis VA Health Care System located at One Veterans Drive, Minneapolis, MN 55417. The contract is managed by Contracting Officer Traci Johannes. While the solicitation specifies that reagents must meet FDA regulatory categories such as In Vitro Diagnostic (IVD) or Analyte Specific Reagent (ASR), no specific pricing, CLIN structures, or socioeconomic set-asides are applied. Responses are required in the form of a capabilities statement submitted electronically by the August 2026 deadline.
Network Contract Office 23 (36C263)

POSTED

6 days ago

DEADLINE

in 5 days
View Details
NAICS: 325413
New
Federal
Procurement of commercial-off-the-shelf (COTS) proprietary BioFire diagnostic assay kits and refurbished systems
Solicitation # N6817126QN076
The Naval Supply Systems Command Fleet Logistics Center Sigonella intends to award a firm-fixed-price, sole-source purchase order to Bio Fire Defense, LLC for the procurement of proprietary BioFire diagnostic assay kits and four refurbished FilmArray 2.0 systems. This acquisition supports the Naval Medical Research Unit Europe, Africa, Central in its infectious disease surveillance and research operations across Europe, Africa, and the Middle East. The required materials include various specialized panels for global fever, blood culture identification, gastrointestinal, and respiratory diagnostics, all of which must be delivered to NAS II Sigonella, Italy, within 15 calendar days of the order. The sole-source justification is based on the proprietary nature of the consumables and a Foreign Ownership, Control, or Influence mitigation agreement, which mandates that U.S. Federal Government entities procure these specific biological defense assets exclusively through Bio Fire Defense, LLC. While this is a notice of intent for a sole-source award, interested parties may submit capability statements by August 31, 2026. To be considered, respondents must provide evidence of FOCI agreement compliance, the ability to provide exact part numbers without substitutions, cold-chain logistical capabilities for delivery to Italy, and confirmation of valid OEM warranty support.
Navsup Flc Sigonella Naples Office

POSTED

6 days ago

DEADLINE

in 11 days
View Details